Over the past 25 years, pharmaceutical companies have promoted opioid use in ways that were often neither safe, nor effective, causing significant harm on patients and consumers.

Regulatory failures made by the US Food and Drug Administration (FDA) in approving and labelling new products, including deceptive safety studies, allowed for this to reach crisis point.

[…Continued]